Watermark
  Back to Search Results

BGB-A317-Sitravatinib-301

Terminated

Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-Sitravatinib-301

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04921358

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2022-001779-15

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20211410/CTR20211409

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan